BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36600256)

  • 1. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
    Zhang B; Xu T
    World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma.
    Zheng J; Peng L; Zhang S; Liao H; Hao J; Wu S; Shen H
    Front Immunol; 2023; 14():1275033. PubMed ID: 38053997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
    Meng L; Yang Y; Hu X; Zhang R; Li X
    J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing the prognostic and clinicopathological significance of systemic immune-inflammation index in patients with different stage prostate cancer: A systematic review and meta-analysis.
    Qi W; Zhou Y; Liu Z; Wang J; Lv G; Zhong M; Wang W; Li R; Chen S; Shi B; Zhu Y
    Front Med (Lausanne); 2022; 9():1052943. PubMed ID: 36388917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
    Mao H; Yang F
    Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis.
    Wang Y; Ni Q
    Ann Med; 2023 Dec; 55(1):808-819. PubMed ID: 36892953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
    Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
    Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
    Zeng Z; Xu S; Wang D; Qin G
    Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Zhou Y; Dai M; Zhang Z
    Front Oncol; 2022; 12():814727. PubMed ID: 35186750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
    Zhang Y; Sun Y; Zhang Q
    Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
    Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.
    Zhang B; Yao W
    World J Surg Oncol; 2022 Sep; 20(1):320. PubMed ID: 36171621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
    Qiu Y; Zhang Z; Chen Y
    Front Oncol; 2021; 11():537140. PubMed ID: 33777726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
    Li X; Zhang S; Lu J; Li C; Li N
    Front Surg; 2022; 9():922595. PubMed ID: 36090319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
    Fan Z; Shou L
    Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.
    Wang Y; Li Y; Chen P; Xu W; Wu Y; Che G
    Ann Transl Med; 2019 Sep; 7(18):433. PubMed ID: 31700869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
    Ji Y; Wang H
    World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer.
    Li J; Cao D; Huang Y; Xiong Q; Tan D; Liu L; Lin T; Wei Q
    Front Immunol; 2022; 13():865643. PubMed ID: 35572533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis.
    Dong M; Shi Y; Yang J; Zhou Q; Lian Y; Wang D; Ma T; Zhang Y; Mi Y; Gu X; Fan R
    Ther Adv Med Oncol; 2020; 12():1758835920937425. PubMed ID: 32699557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinical pathological significance of the systemic immune-inflammation index in urothelial carcinoma: a systematic review and meta-analysis.
    Wang Y; Hao X; Li G
    Front Oncol; 2024; 14():1322897. PubMed ID: 38595827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.